OBI Pharma announces COVID-19 vaccine clinical trials to start in 2022
02/08/2022 08:38 PM
Taipei, Feb. 8 (CNA) Taiwan-based biotech firm OBI Pharma Inc. announced Tuesday that the COVID-19 vaccine it developed called BCVax will enter phase 1 & 2 clinical trials in the second half of this year.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Taiwan shares close up 0.2%
12/11/2023 01:53 PM - Politics
Parties draw lots for placement on Taiwan's presidential ballot
12/11/2023 12:32 PM - Society
Mercury forecast to soar past 30 degrees Monday in western Taiwan
12/11/2023 11:49 AM - Business
U.S. dollar up in Taipei trading
12/11/2023 10:24 AM - Society
Taiwan headline news
12/11/2023 10:22 AM